May 20, 2020
Virpax scores at the pre-IND meeting with FDA on Epoladerm for Knee Osteoarthritis
Virpax Pharmaceuticals has successfully completed a pre-Investigational New Drug (IND) Application meeting with the U.S. Food and Drug Administration (FDA)…